The results showed that neutralization of IL-17A, IL-17F, or both substantially alleviated the DSS-induced colitis development in wild-type mice, with more obvious effect when simultaneously blocking both (Supplementary Fig. 16a–f). This evidence concerns the gene IL17A and colitis.